Sign up to get updates from us
What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville shares his biggest takeaways, from the importance of founder-market fit to the need to challenge assumptions in a nascent field.
Learn more about your ad choices. Visit megaphone.fm/adchoices
